Literature DB >> 28079718

Longitudinal HIV Care Trajectories in North Carolina.

Kimberly A Powers1, Erika Samoff, Mark A Weaver, Lynne A Sampson, William C Miller, Peter A Leone, Heidi Swygard.   

Abstract

BACKGROUND: Long-term HIV care and treatment engagement is required for maximal clinical and prevention benefits, but longitudinal care patterns are poorly understood. We used the last 10 years' worth of HIV surveillance data from North Carolina to describe longitudinal HIV care trajectories from diagnosis.
METHODS: We conducted a retrospective, population-based cohort study of all persons newly diagnosed with HIV in North Carolina between March 31, 2006 and March 31, 2015 (N = 16,207). We defined HIV care attendance in each 3-month and 6-month interval after diagnosis as the presence of viral load and/or CD4 records (care visit proxies) in the interval. We used group-based trajectory modeling to identify common care trajectories and baseline predictors thereof.
RESULTS: A predicted 26% of newly HIV-diagnosed persons showed consistently high care attendance over time; ∼16% exhibited steadily declining attendance; ∼26% showed consistently low attendance; ∼17% had initially weak attendance with an increase starting ∼1.5 year later; and ∼15% showed initially weak attendance with an increase starting ∼3 years later. Older age at diagnosis was protective against all suboptimal trajectories (with the "consistently high" pattern as referent), and being a man who has sex with men was protective against 3 of the 4 suboptimal patterns.
CONCLUSIONS: As measured by surveillance-based laboratory proxies, most newly HIV-diagnosed persons exhibited suboptimal care trajectories, but there was wide variation in the particular pathways followed. The insights provided by this analytical approach can help to inform the design of epidemic models and tailored interventions, with the ultimate goal of improving HIV care engagement and transmission prevention.

Entities:  

Mesh:

Year:  2017        PMID: 28079718      PMCID: PMC5289300          DOI: 10.1097/QAI.0000000000001234

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  23 in total

1.  Analyzing developmental trajectories of distinct but related behaviors: a group-based method.

Authors:  D S Nagin; R E Tremblay
Journal:  Psychol Methods       Date:  2001-03

2.  Engagement in HIV care among HIV-positive men who have sex with men from 21 cities in the United States.

Authors:  Gabriela Paz-Bailey; Huong Pham; Alexandra M Oster; Amy Lansky; Trista Bingham; Ryan E Wiegand; Elizabeth Dinenno; Jacek Skarbinski; James D Heffelfinger
Journal:  AIDS Behav       Date:  2014-04

3.  Fighting HIV/AIDS in Washington, D.C.

Authors:  Alan E Greenberg; Shannon L Hader; Henry Masur; A Toni Young; Jennifer Skillicorn; Carl W Dieffenbach
Journal:  Health Aff (Millwood)       Date:  2009 Nov-Dec       Impact factor: 6.301

Review 4.  The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection.

Authors:  Edward M Gardner; Margaret P McLees; John F Steiner; Carlos Del Rio; William J Burman
Journal:  Clin Infect Dis       Date:  2011-03-15       Impact factor: 9.079

5.  Vital signs: HIV prevention through care and treatment--United States.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-12-02       Impact factor: 17.586

6.  Impact of age on retention in care and viral suppression.

Authors:  Baligh R Yehia; Peter Rebeiro; Keri N Althoff; Allison L Agwu; Michael A Horberg; Hasina Samji; Sonia Napravnik; Kenneth Mayer; Ellen Tedaldi; Michael J Silverberg; Jennifer E Thorne; Ann N Burchell; Sean B Rourke; Anita Rachlis; Angel Mayor; Michael J Gill; Anne Zinski; Michael Ohl; Kathryn Anastos; Alison G Abraham; Mari M Kitahata; Richard D Moore; Kelly A Gebo
Journal:  J Acquir Immune Defic Syndr       Date:  2015-04-01       Impact factor: 3.731

7.  Depression and anxiety symptoms: onset, developmental course and risk factors during early childhood.

Authors:  Sylvana M Côté; Michel Boivin; Xuecheng Liu; Daniel S Nagin; Mark Zoccolillo; Richard E Tremblay
Journal:  J Child Psychol Psychiatry       Date:  2009-06-10       Impact factor: 8.982

8.  Retention among North American HIV-infected persons in clinical care, 2000-2008.

Authors:  Peter Rebeiro; Keri N Althoff; Kate Buchacz; John Gill; Michael Horberg; Hartmut Krentz; Richard Moore; Timothy R Sterling; John T Brooks; Kelly A Gebo; Robert Hogg; Marina Klein; Jeffrey Martin; Michael Mugavero; Sean Rourke; Michael J Silverberg; Jennifer Thorne; Stephen J Gange
Journal:  J Acquir Immune Defic Syndr       Date:  2013-03-01       Impact factor: 3.731

9.  Life course turning points: the effect of grade retention on physical aggression.

Authors:  Daniel S Nagin; Linda Pagani; Richard E Tremblay; Frank Vitaro
Journal:  Dev Psychopathol       Date:  2003

10.  Vital Signs: HIV diagnosis, care, and treatment among persons living with HIV--United States, 2011.

Authors:  Heather Bradley; H Irene Hall; Richard J Wolitski; Michelle M Van Handel; Amy E Stone; Michael LaFlam; Jacek Skarbinski; Darrel H Higa; Joseph Prejean; Emma L Frazier; Roshni Patel; Ping Huang; Qian An; Ruiguang Song; Tian Tang; Linda A Valleroy
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-11-28       Impact factor: 17.586

View more
  9 in total

Review 1.  Novel Longitudinal Methods for Assessing Retention in Care: a Synthetic Review.

Authors:  Aaloke Mody; Khai Hoan Tram; David V Glidden; Ingrid Eshun-Wilson; Kombatende Sikombe; Megha Mehrotra; Jake M Pry; Elvin H Geng
Journal:  Curr HIV/AIDS Rep       Date:  2021-05-04       Impact factor: 5.071

2.  Improving HIV Care Engagement in the South from the Patient and Provider Perspective: The Role of Stigma, Social Support, and Shared Decision-Making.

Authors:  Barbara S Taylor; Laura Fornos; Jesse Tarbutton; Jana Muñoz; Julie A Saber; Delia Bullock; Roberto Villarreal; Ank E Nijhawan
Journal:  AIDS Patient Care STDS       Date:  2018-09       Impact factor: 5.078

3.  Indirect comparison of 48-week efficacy and safety of long-acting cabotegravir and rilpivirine maintenance every 8 weeks with daily oral standard of care antiretroviral therapy in participants with virologically suppressed HIV-1-infection.

Authors:  Vasiliki Chounta; Sonya J Snedecor; Sterling Wu; Nicolas Van de Velde
Journal:  BMC Infect Dis       Date:  2022-05-04       Impact factor: 3.667

4.  CROI 2018: Advances in Antiretroviral Therapy.

Authors:  Hong-Van Tieu; Barbara S Taylor; Joyce Jones; Timothy J Wilkin
Journal:  Top Antivir Med       Date:  2018-05

Review 5.  Advances in Long-Acting Agents for the Treatment of HIV Infection.

Authors:  Aadia I Rana; Jose R Castillo-Mancilla; Karen T Tashima; Raphael L Landovitz
Journal:  Drugs       Date:  2020-04       Impact factor: 9.546

6.  HIV viral load trajectories of women living with HIV in Metro Vancouver, Canada.

Authors:  Putu Duff; Kate Shannon; Melissa Braschel; Flo Ranville; Mary Kestler; Ruth Elwood Martin; Andrea Krüsi; Kathleen Deering
Journal:  Int J STD AIDS       Date:  2020-12-08       Impact factor: 1.359

7.  Annual and durable HIV retention in care and viral suppression among patients of Peter Ho Clinic, 2013-2017.

Authors:  Debbie Y Mohammed; Lisa Marie Koumoulos; Eugene Martin; Jihad Slim
Journal:  PLoS One       Date:  2020-12-29       Impact factor: 3.240

8.  Longitudinal engagement trajectories and risk of death among new ART starters in Zambia: A group-based multi-trajectory analysis.

Authors:  Aaloke Mody; Ingrid Eshun-Wilson; Kombatende Sikombe; Sheree R Schwartz; Laura K Beres; Sandra Simbeza; Njekwa Mukamba; Paul Somwe; Carolyn Bolton-Moore; Nancy Padian; Charles B Holmes; Izukanji Sikazwe; Elvin H Geng
Journal:  PLoS Med       Date:  2019-10-29       Impact factor: 11.069

9.  Profiles of HIV Care Disruptions Among Adult Patients Lost to Follow-up in Zambia: A Latent Class Analysis.

Authors:  Aaloke Mody; Kombatende Sikombe; Laura K Beres; Sandra Simbeza; Njekwa Mukamba; Ingrid Eshun-Wilson; Sheree Schwartz; Jake Pry; Nancy Padian; Charles B Holmes; Carolyn Bolton-Moore; Izukanji Sikazwe; Elvin H Geng
Journal:  J Acquir Immune Defic Syndr       Date:  2021-01-01       Impact factor: 3.771

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.